221.2 Follow the leader: HLA-B leader dimorphism predicts long-term survival following lung transplantation
Dr. Lucy Sullivan, Australia
221.1 ABO-incompatible transplantation following enzymatic A-antigen removal in a mouse model: A-antigen re-expression and prevention of early antibody-mediated rejection
Mr. Tate Erickson, Canada
221.3 Panel Reactive Antibody Levels decline with increasing Age: Potential of augmented Organ Availability and improved Outcomes for sensitized older Recipients
Mr. Merih Gizlenci, United States
221.4 Antibodies against Eplet mismatches can help identify the cause of ABMR in absence of DSAs on single antigen bead assay in transplantation
Dr. Shruti N Tapiawala, India
221.5 Advancing renal transplant patient care: Unveiling eplet mismatch thresholds for precise risk assessment and prognosis
Dr. Ahmed Mostafa, Canada
221.6 Development of a calculated panel reactive antibody calculator for the United Arab Emirates
Prof. Gehad ElGhazali, United Arab Emirates
221.7 Baskent University transplantation immunology algorithm and results
Bilkay Basturk, Turkey
221.8 Argentina's leap into the cPRA Era: embracing transplantation advancements